The cooperation includes the advancement of an unique long-acting GLP-1 receptor villain.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/gubra-signs-cooperation-agreement-with-amylyx-pharmaceuticals/
Gubra signs cooperation agreement with Amylyx Pharmaceuticals
赞 (0)
关于作者
Report: Phase 2 data will continue to dominate biotech venture capital investment in 2025
上一篇
30 12 月, 2024 8:19 下午
相关推荐
-
Helpr Employer-Subsidized Family Care App with Patented “My Choice” Technology Expands Service to 150+ Countries, Adds New Features
LOS ANGELES–(SERVICE CORD)– #Helpr– Helpr aids workers obtain high quality look after kids, companions, moms and dads, and animals, with an alternative to pick su…
-
ABB enables digital control system evolution project at Naphtachimie plant in France
The challenge evolves ABB’s Distributed Management System (DCS) from a legacy model Advant MOD 300 to the brand new AC 800M, extending the plant’s life, in addition to enhancing ef…
-
Lenovo se convierte en el Socio Tecnológico Oficial de la FIFA
SEATTLE–(BUSINESS WIRE)–En el encuentro anual sobre innovación Tech World de Lenovo, Lenovo y la FIFA han hecho público que la multinacional será el Socio Tecnológico O…
-
AI speech-to-text can hallucinate violent language
Converse just a little too haltingly and with lengthy pauses, and OpenAI’s speech-to-text transcriber would possibly put dangerous, violent phrases in your mouth, Cornell researche…
